1.
TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling. Clinics [Internet]. 2022 Oct. 23 [cited 2024 Jun. 2];77:100122. Available from: https://journals.usp.br/clinics/article/view/213575